NCT01297517View on ClinicalTrials.gov

Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%

PHASE3CompletedINTERVENTIONAL
Enrollment

1,001

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension

DRUG

Brinzolamide ophthalmic suspension, 1%

DRUG

Brimonidine tartrate ophthalmic solution, 0.2%

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY